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Pre-pregnancy obesity and non-adherence
to multivitamin use: findings from the
National Pregnancy Risk Assessment
Monitoring System (2009–2011)
Saba W. Masho1,2,3*, Amani Bassyouni1 and Susan Cha1
Abstract
Background: Although adequate folic acid or multivitamins can prevent up to 70 % of neural tube defects,
the majority of U.S. non-pregnant women of childbearing age do not use multivitamins every day. Factors
influencing consistent multivitamin use are not fully explored. This study aims to investigate the association
between pre-pregnancy body mass index (BMI) and multivitamin use before pregnancy using a large,
nationally representative sample of women with recent live births.
Methods: The national 2009–2011 Pregnancy Risk Assessment Monitoring System data were analyzed. The
sample included women with recent singleton live births (N = 104,211). The outcome of interest was
multivitamin use which was categorized as no multivitamin use, 1–3 times/week, 4–6 times/week, and daily
use. Maternal BMI was examined as underweight (<18.50 kg/m2), normal weight (18.50–24.99 kg/m2),
overweight (25.00–29.99 kg/m2), and obese (≥30.00 kg/m2). Multinomial logistic regression was conducted,
and adjusted odds ratios and 95 % confidence intervals were calculated.
Results: Compared to women with normal weight, overweight and obese women had significantly increased
odds of not taking multivitamins after adjusting for confounding factors. Further, the lack of multivitamin use increased
in magnitude with the level of BMI (ORoverweight = 1.2, 95 % CI = 1.1–1.3; ORobese = 1.4, 95 % CI = 1.2–1.5).
Conclusions: Obese and overweight women were less likely to follow the recommendation for preconception
multivitamin use compared to normal weight women. All health care professionals must enhance preconception care
with particular attention to overweight and obese women. Preconception counseling may be an opportunity to
discuss healthy eating and benefits of daily multivitamin intake before pregnancy.
Keywords: Obesity, Body mass index, Vitamins, Dietary supplements, Preconception care, PRAMS
Background
Multivitamin use has increased over the past decade and
is the most commonly used dietary supplement in the
United States [1]. According to the Centers for Disease
Control and Prevention (CDC), approximately 34 %
of women aged 20–39 used a dietary supplement
containing folic acid and 30 % reported using supple-
mental vitamin D in 2003–2006 [2]. Additionally, na-
tionally representative data that come from the
Behavioral Risk Factor Surveillance System (BRFSS)
indicate 78 % of pregnant women and 47 % of non-
pregnant women of childbearing age (18–44) use
multivitamins daily [3]. Since 1991, the U.S. Public
Health Service has recommended that all women who
plan on becoming pregnant consume 400 μg of folic
acid daily beginning one month before trying to get
pregnant [4, 5]. However, a recent report from the
CDC finds that more than 63 % of women do not
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take multivitamins during the month before preg-
nancy [6]. The lack of multivitamin use is a public
health concern given that adequate folic acid or mul-
tivitamins can prevent 50to 70 % of pregnancies af-
fected by serious birth defects, (i.e., spina bifida and
anencephaly) [7]. For instance, one hospital-based
case–control study reported the use of folic acid
(0.4 mg daily for three months before and after concep-
tion, and continuing for at least one month) was associ-
ated with decreased neural tube defects (OR = 0.32,
95 % CI = 0.17–0.58), but the protective effects of folic
acid supplementation was attenuated for overweight or
obese women [8]. Similarly, a recent Cochrane review,
women receiving folic acid with micronutrients were
less likely to have infants with neural tube defects than
women receiving other or same micronutrients without
folic acid (RR = 0.31, 95 % CI = 0.16–0.60; RR = 0.29,
95 % CI = 0.12–0.70) [9].
Additionally, prenatal iron deficiency anemia during
pregnancy has detrimental effects on infant mental de-
velopment. A cohort study that followed women during
the last trimester to 24 months after delivery reported a
lower mental development index among children ex-
posed to prenatal iron deficiency anemia at 12, 18, and
24 months of age; however, supplementation with suffi-
cient iron was found to be protective [10]. Prenatal
vitamin intake during pregnancy has been shown to sig-
nificantly reduce the risk of birth defects, low birth
weight, small for gestational age, and spontaneous pre-
term birth [11–14].
Despite the benefits of multivitamins or folic acid use
before pregnancy, non-adherence to recommendations
has been observed in some populations. A large propor-
tion of women who are younger (under 20 years of age),
of racial/ethnic minority group, or without history of
neural tube defects do not take folic acid supplements
before pregnancy [15]. Other risk factors for inconsistent
or no use of multivitamin during pregnancy include low
income and below high school educational attainment
[3, 16]. One study conducted among African-American
and Hispanic women identified adverse side effects, large
size of pills, and bad taste and smell as possible barriers
to multivitamin use [17]. Lack of knowledge regarding
multivitamin use, dose, duration, timing and efficacy can
also lead to non-adherence to multivitamin use during
pregnancy [18]. On the other hand, Kimmons et al. re-
ported that obese women were less likely to use multivi-
tamins than normal weight women [19].
To the authors’ knowledge, only a few studies have
assessed the relationship between obesity and multivita-
min use [20–22]. For example, a nested retrospective co-
hort study conducted by Farah et al. found that obese
and overweight women reported less folic acid use be-
fore pregnancy compared to women of normal weight
[20]. In yet another study, Case et al. used data from
the Texas Behavioral Risk Factor Surveillance System
(1999–2003) and found that obese but not overweight
women were less likely to take folic acid every day
compared to normal weight/underweight women [21].
Kimmons et al. examined the association between
body mass index (BMI) and serum micronutrient
levels among U.S. adults and found that premeno-
pausal women who were overweight and obese were
more likely to have low levels of micronutrients (e.g.,
folate) than normal weight premenopausal women
[22]. Decreased folic acid intake may be due to un-
planned pregnancies and failed contraceptive methods
prevalent in obese women [23]. Although findings in
these studies provide critical evidence, these studies
have notable limitations. The study by Farah et al.
had a small sample size (n = 288) and included only
Caucasian women, making it less generalizable to mi-
norities who may be at risk for poor pregnancy out-
comes [20]. Similarly, Case et al. only considered
women from Texas and excluded those who were
younger than 18 years old [21]. In the study by Kimmons
et al., micronutrient intake was not taken into consider-
ation, and any adult women (≥19 years) were categorized
as premenopausal if they reported menstruation in the
previous 12 months, possibly including older women who
were no longer of reproductive age (15–44) [22]. The ob-
served shortcomings in the study designs, problems re-
lated to small sample sizes and homogenous study
populations, warrant further investigation of the relation-
ship between obesity and multivitamin use.
This study aims to investigate the association between
pre-pregnancy BMI and multivitamins use before preg-
nancy using a large, nationally representative sample of
women with recent live births.
Methods
The 2009–2011 Pregnancy Risk Assessment Monitoring
System (PRAMS) [24] was analyzed to assess the rela-
tionship between pre-pregnancy BMI and multivitamin
use before pregnancy. PRAMS is an ongoing national
surveillance program through the CDC in collaboration
with participating state health departments. Data on
women with recently delivered live-born infants are
drawn from state birth certificate files. PRAMS utilizes a
complex multistage sampling design and oversamples
women from minority groups and high risk populations
to ensure adequate numbers for analyses (e.g., low
weight births). Accordingly, oversampling is accounted
for by analysis weights provided by CDC to obtain na-
tionally representative estimates. Women are contacted
by mail or telephone to participate, and information re-
garding their attitudes, behaviors, and experiences before
and during pregnancy, and a few months after birth are
Masho et al. BMC Pregnancy and Childbirth  (2016) 16:210 Page 2 of 10
obtained from those who consent to participate. In order
to ensure comparability of data, PRAMS establishes
standardized surveillance methods and tools for data
collection.
A total of 112,358 women (unweighted N) participated
in PRAMS for 2009 to 2011. For this analysis women
with singleton live births and valid responses to ques-
tions on pre-pregnancy BMI and multivitamin use a
month prior to pregnancy were included. The study
sample consisted of 104,211 women (unweighted num-
ber) representing 5,032,562 women (weighted number).
Women who delivered multiple births (e.g., twins,
triplets) were excluded from the analysis, as consistent
with the literature [25, 26]. This study analyzed a de-
identified publicly available data and was approved as
exempt by the Institutional Review Board at Virginia
Commonwealth University.
The exposure, maternal pre-pregnancy BMI was de-
termined by self-report weight and height prior to
pregnancy (kilograms/meters2). Participants were asked,
“Just before you got pregnant with your new baby, how
much did you weigh?” and “How tall are you without
shoes?” Using BMI classifications from the World Health
Organization, pre-pregnancy BMI was categorized as
underweight (<18.5 kg/m2), normal weight (18.5–
24.9 kg/m2), overweight (25.0–29.9 (kg/m2) and obese
(≥30.0 kg/m2) [27].
The outcome of interest was the frequency of multi-
vitamin use one month prior to pregnancy. Women
were asked, “During the month before you got pregnant
with your new baby, how many times a week did you
take a multivitamin, a prenatal vitamin, or a folic acid
vitamin?” Consistent with the literature, responses were
categorized into four levels: “I didn’t take a multivita-
mins, prenatal vitamins or folic acid vitamins at all” (i.e.,
Not at all), “1 to 3 times a week”, “4 to 6 times a week”,
or “every day of the week” [28].
Covariates examined included maternal socio-
demographic factors, access to resources and care,
behavioral and lifestyle factors, reproductive health
factors and medical complications [15, 29–31]. Socio-
demographic factors included maternal age (≤19; 20–24;
25–29; 30–35; >35), race/ethnicity (White non-Hispanic;
Black non-Hispanic; Hispanic; other non-Hispanic), edu-
cation (<high school; high school; >high school), marital
status (married; not married), and household income level
(<20,000; 20,000–34,999; 35,000–49,999; ≥50,000). Factors
related to access to care and services included health in-
surance 12 months before pregnancy (private; Medicaid;
multiple; other; none). Maternal health behaviors prior to
pregnancy consisted of smoking (yes; no), drinking alcohol
(yes; no), dieting, i.e., changing eating habits any time dur-
ing the 12 months prior to pregnancy (yes; no), and exer-
cise habits, i.e., exercising three or more days of the week
any time during the last 12 months before pregnancy (yes;
no). Maternal health conditions included preconception
morbidities such as diabetes (yes; no) and hypertension
(yes; no). Previous live pregnancy, pregnancy intention
and intimate partner violence were also evaluated as
confounders.
All analyses were conducted using SAS statistical soft-
ware version 9.4 to account for the complex survey
design. Descriptive statistics including unweighted fre-
quencies and weighted percentages were generated to
assess the distribution of maternal characteristics and
multivitamin use. Multinomial logistic regression models
for the outcome of interest were used to obtain crude
and adjusted odds ratios (COR and AOR, respectively)
and 95 % confidence intervals (CI). Adjusted estimates
controlled for domains of covariates such as maternal
socio-demographic characteristics, medical-reproductive
factors, and socio-behavioral characteristics.
Results
The majority of the study population was between the
ages of 20–29 years (53 %), Non-Hispanic White (60 %),
married (61 %), reported high school or more education
(58 %), earned less than $50,000 (64 %), and privately in-
sured (56 %) (Table 1). Approximately 4.4 % of women
were underweight, 50.4 % were normal weight, 24.1 %
were overweight, and 21.2 % obese. More than half of
women (55.4 %) did not take multivitamins at any time,
8.4 % used multivitamins 1–3 times per week, 6.1 %
used multivitamins 4–6 times per week, and 30.2 % used
multivitamins every day. Multivitamin intake was
strongly associated with socio-demographic character-
istics (e.g., marital status, income, race/ethnicity),
medical-reproductive (e.g., parity, pre-pregnancy dia-
betes), and social-behavioral factors (e.g., smoking
prior to pregnancy, intimate partner violence) (Table 2).
Pre-pregnancy BMI was significantly associated with age,
race, marital status, education, income, insurance, parity,
pre-pregnancy diabetes, pre-pregnancy hypertension,
pregnancy intention, smoking prior to pregnancy, al-
cohol use, exercise, dieting, and intimate partner vio-
lence (Table 3).
The unadjusted analyses showed a statistically signifi-
cant association between pre-pregnancy BMI and multi-
vitamin use (Table 4). Underweight and obese women
were 1.6 times as likely to report no multivitamin use
compared to women of normal weight (COR = 1.6, 95 %
CI = 1.4–1.8; COR = 1.6, 95 % CI = 1.5–1.7, respectively).
In addition, overweight women had 1.3 times the odds
of reporting no intake compared to women with normal
BMI (COR = 1.3, 95 % CI = 1.2–1.4). When controlling
for socio-demographic characteristics such as maternal
age, race, marital status, education, income, and health
insurance, the odds of non-adherence to multivitamin
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use stayed significant for overweight and obese women
(AOR = 1.2, 95 % CI = 1.1–1.3; AOR = 1.4, 95 % CI =
1.3–1.5, respectively). However, estimates were no longer
significant for the underweight group (AOR = 1.2, 95 %
CI = 1.0–1.4). After additionally adjusting for medical-
reproductive factors such as previous live birth, preg-
nancy intention, pre-pregnancy diabetes, and pre-
pregnancy hypertension, the estimates remained consist-
ent for overweight (AOR = 1.2, 95 % CI = 1.2–1.3) and
obese women (AOR = 1.5, 95 % CI = 1.03–1.6). In fact,
overweight and obese women were significantly more
likely to report no multivitamin use compared to normal
weight women (AOR = 1.2, 95 % CI = 1.1–1.3; AOR = 1.4,
95 % CI = 1.2–1.5, respectively) even after controlling for
all covariates including socio-demographic characteristics,
medical-reproductive factors, and socio-behavioral charac-
teristics (i.e., smoking, alcohol consumption, diet, exercise,
and intimate partner violence).
The odds of inadequate multivitamin supplementation,
specifically 1–3 times per week, were higher for obese
women compared to normal weight women (COR = 1.3,
95 % CI = 1.1–1.4). Similar estimates were obtained after
adjusting for socio-demographic and medical-reproductive
factors (AOR = 1.2, 95 % CI = 1.1–1.3). However, there were
no longer significant differences between obese and normal
weight women in fully adjusted models (AOR= 1.1, 95 %
CI = 0.9–1.3). The odds of multivitamin use (4–6 times per
week) remained non-significant for all different weight
groups, even after controlling for all aforementioned
factors.
Discussion
We found that obese and overweight women were less
likely to follow the recommended use of preconception
multivitamins compared to normal weight women. These
findings are consistent with previous studies [20, 21]. Un-
like previous studies, this analysis employed data from a
national survey that provided a large sample size and
representative study population. For instance, contrary to
findings from Farah et al. which were based on a small
sample of Caucasian women, the current study provided
estimates that are more generalizable to the U.S. popula-
tion [20].
Adequate multivitamin use one month prior to preg-
nancy has well-known positive benefits for both mothers
and developing infants. However, the CDC reported that
63 % of women do not take the recommended amount
of multivitamin one month prior to pregnancy [6]. This
is consistent with our study finding that more than half
of the women did not take multivitamin during the
preconception period. While there are several possible
reasons for lack of multivitamin use (e.g., simply forget-
ting), a growing body of literature has attributed this
lack of adherence to unintended pregnancies [32–34].
Table 1 Distribution of the study population characteristics
Total Weighted N = 5 032 562
%
Age
≤ 19 9.3
20–24 22.9
25–29 29.7
30–35 24.7
> 35 13.9
Race/Ethnicity
White, non-Hispanic 60.4
Black, non-Hispanic 13.7
Hispanic 17.8
Other, non-Hispanic 8.2
Married 61.0
Education
< High school 15.8
High school 26.3
> High school 57.9
Income
< $20,000 36.2
$20,000–34,999 17.0
$35,000–49,999 10.3
v ≥ $50,000 36.5
Pre-pregnancy Insurance
Private 55.9
Medicaid 15.6
Other 1.9
Multiple 3.4
No insurance 23.2
Previous live birth
0 42.0
v1 - 2 47.5
≥ 3 10.6
Pre-pregnancy diabetes 2.2
Pre-pregnancy hypertension 8.9
Unintended pregnancy 42.5
Pre-pregnancy smoking 24.6
Average number of alcohol drink/week
None 17.0
Up to 3 67.7
4 or more 15.3
Pre-pregnancy dieting 28.5
Pre-pregnancy exercising 42.2
Intimate partner violence 3.0
Weighted N = adjusted for the complex sampling design and represents the
total population that the sampled was derived from
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Table 2 Prevalence of multivitamin intake by maternal characteristics
No intake
n = 2 946 523
1–3 times/week
n = 444 399
4–6 times/week
n = 323 867
Every day
n = 1 607 653
P-value
Weighted row %
Body mass index <.0001
Underweight 61.6 8.5 4.6 25.3
Normal Weight 51.09 8.50 6.92 33.49
Overweight 56.47 8.33 6.07 29.13
Obese 60.9 8.3 5.0 25.8
Socio-demographic
Age <.0001
≤ 19 77.6 5.6 1.9 14.9
20–24 71.8 7.3 3.8 17.1
25─29 54.3 8.7 6.2 30.8
30–35 42.3 9.2 8.0 40.5
> 35 38.5 9.8 8.9 42.8
Race/Ethnicity <.0001
White, non-Hispanic 49.2 8.6 7.5 34.7
Black, non-Hispanic 66.6 9.1 3.5 20.8
Hispanic 66.0 7.2 3.9 22.9
Other, non-Hispanic 54.1 8.2 6.1 31.6
Married <.0001
Yes 43.5 9.2 8.2 39.1
Other 73.2 7.1 2.9 16.8
Education <.0001
< High school 71.0 6.7 2.9 19.4
High school 68.6 7.1 3.6 20.7
> High school 44.2 9.5 8.2 38.1
Income <.0001
< $20,000 72.2 7.5 3.1 17.2
$20,000–34,999 62.7 8.6 5.2 23.5
$35,000–49,999 53.1 9.6 7.6 29.7
≥ $50,000 33.0 9.0 9.8 48.2
Pre-pregnancy Insurance <.0001
Private 42.8 9.0 8.2 40.0
Medicaid 66.8 8.1 3.6 21.5
Other 61.3 8.7 4.5 25.5
Multiple 57.4 8.1 3.9 30.6
No insurance 73.5 7.2 3.6 15.7
Medical-reproductive
Previous live birth <.0001
0 54.8 7.1 5.4 32.7
1–2 54.6 9.0 6.6 29.8
≥ 3 60.94 10.1 6.5 22.54
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Previous studies reported that obese women have higher
rates of unintended pregnancies compared to their nor-
mal weight counterpart. Huber et al. analyzed PRAMS
database and reported that obese women are at higher
risk of unintended pregnancy compared to normal
weight women (AOR = 1.75, 95 % CI = 1.21–2.52) [33].
Similarly, Garbers et al. found that obese women had
more than twice the odds of unintended pregnancy
(AOR = 2.81, 95 % CI = 1.41–5.60) [35]. Nevertheless,
findings from the current study demonstrated that obese
women had a higher odds of not using multivitamins
even after adjusting for pregnancy intention.
Another possible explanation for the association
between obesity and lack of multivitamin use may be
that overweight and obese women are less likely to take
dietary supplements. This was demonstrated by Radimer
et al. who reported that obese adults were less likely to
engage in healthy behaviors including multivitamin use
[36]. Furthermore, it is also possible that overweight
and obese women may not receive the appropriate
counseling for preconception multivitamin use. The
CDC reports that obese/overweight women are more
likely to receive suboptimal preconception care in
contrast to normal weight women [6]. Health care
providers may play an important role in multivitamin
use prior to pregnancy. However, only one of six ob-
stetrician/gynecologists or family physicians provides
preconception care to prenatal care patients [37].
The strengths of this study consist of having a large
nationally-representative data that utilizes standardized
methods of data collection. These methods allow for
optimal comparison among participating states. The
PRAMS data also allowed this study to account for
important socio-demographic, medical, and high-risk
behavioral factors. Despite these strengths, the study has
some limitations. The cross-sectional design makes it
difficult to determine causality between exposure and
outcome. However, this study included women who had
a live birth and the question about preconception multi-
vitamin use clearly referred to one month prior to
Table 2 Prevalence of multivitamin intake by maternal characteristics (Continued)
Pre-pregnancy diabetes <.0001
No 55.5 8.3 6.1 30.1
Yes 50.9 8.6 4.7 35.8
Pre-pregnancy hypertension <.0001
No 56.1 8.3 6.2 29.4
Yes 47.3 8.7 4.9 39.1
Pregnancy intention <.0001
Unintended 71.9 8.1 4.00 16.0
Intended 43.0 8.5 7.6 40.9
Socio-behavioral
Pre-pregnancy smoking <.0001
No 49.9 8.8 6.8 34.5
Yes 72.5 6.9 3.9 16.7
Average # of alcohol drink/week <.0001
None 55.1 6.9 5.2 32.8
Up to 3 52.5 8.6 7.2 31.7
v4 or more 58.5 8.1 7.0 26.4
Pre-pregnancy dieting <.0001
No 57.2 7.8 5.7 29.3
Yes 50.6 9.8 7.1 32.5
Pre-pregnancy exercising <.0001
No 63.1 7.8 4.8 24.3
Yes 44.5 9.0 7.9 38.6
Intimate partner violence <.0001
No 54.6 8.4 6.2 30.8
Yes 72.9 7.4 3.1 16.6
Weighted N = adjusted for the complex sampling design and represents the total population that the sampled was derived from
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Table 3 Maternal characteristics by Body Mass Index
Underweight
n = 219 560
Normal Weight
n = 2 534 187
Overweight
n = 1 212 554
Obese
n = 1 066 261
P-value
Weighted row %
Socio-demographic
Age <.0001
≤ 19 17.4 10.9 7.4 5.8
20–24 30.9 22.2 23.1 22.7
25–29 26.7 28.5 29.8 31.0
30–35 16.8 25.0 24.7 25.4
> 35 8.3 13.4 15.0 15.1
Race/Ethnicity <.0001
White, non-Hispanic 60.4 63.7 56.0 56.2
Black, non-Hispanic 11.7 10.8 15.6 18.7
Hispanic 14.8 16.0 20.4 19.8
Other, non-Hispanic 13.1 9.4 7.1 5.4
Married <.0001
Yes 52.2 63.5 60.5 57.4
Other 47.8 36.5 39.5 42.6
Education <.0001
< High school 22.2 15.1 16.1 16.0
High school 29.4 23.6 27.2 31.2
> High school 48.4 61.4 56.6 52.9
Income <.0001
< $20,000 48.9 32.9 36.7 40.8
$20,000–34,999 15.0 15.4 17.7 20.4
$35,000–49,999 9.1 9.8 10.6 11.3
≥ $50,000 27.0 41.9 35.1 27.5
Pre-pregnancy Insurance <.0001
Private 45.3 60.0 54.8 49.3
Medicaid 20.9 13.9 15.2 19.1
Other 2.11 1.9 1.9 2.1
Multiple 3.6 3.2 3.3 3.9
No insurance 28.0 21.0 24.8 25.6
Medical-reproductive
Previous live birth <.0001
0 51.6 45.8 38.7 34.7
1–2 40.8 45.7 49.0 51.4
≥ 3 7.6 8.6 12.3 13.9
Pre-pregnancy diabetes 1.6 1.4 2.2 3.9 <.0001
Pre-pregnancy hypertension 7.1 7.1 9.0 13.3 <.0001
Unintended Pregnancy 50.0 40.6 42.0 45.9 <.0001
Socio-behavioral
Pre-pregnancy smoking 30.7 22.5 24.5 28.3 <.0001
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pregnancy. Another limitation of the study is that BMI
and multivitamin use were both self-reported. It is pos-
sible that overweight and obese women may be under-
reporting their weight because of social desirability bias
which may bias the estimate toward the null. Addition-
ally, PRAMS questionnaire is administered several
months after delivery, making women’s answers subject
to recall bias. However, limiting the recall period to no
longer than one year might minimize recall bias. In fact,
PRAMS typically contacts women two to four months
after delivery [38, 39]. Lastly, the effect of preconception
counseling on multivitamin use may have affected the
results but were unavailable in the data. Health educa-
tion and counseling on positive health behaviors during
perinatal care visits may be of interest for future
research.
Conclusions
In summary, overweight and obese women are less likely
to follow the universal recommendation for multivitamin
use one month before pregnancy. This behavior might
increase the risk for serious but preventable outcomes in
infants, such as neural tube defects, anencephaly, mul-
tiple birth defects, small for gestation, and low birth
weight. More research and well-designed studies are
needed to investigate in detail the reasons for inadequate
multivitamin use in obese/overweight women during the
preconception period. Knowing the motivations under-
lying this problem would help health policy makers im-
plement a proper intervention. However, health care
providers and policy makers need to raise awareness of
this significant health problem. Furthermore, all health
care professional should enhance preconception care
during well–woman visits or other routine visits, and
particular attention should be given to obese women.
Preconception counseling presents an opportunity to
discuss healthy eating and healthy weight, as well as the
benefit of daily multivitamin intake before pregnancy.
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